CYH
COMMUNITY HEALTH SYSTEMS INC
NYSE · CIK 1108109
Last close2.72
Daily change-0.03 (-1.09%)
10 Years gain-75.95%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
CYH · STANDARD
SIC 8062 · Services-General Medical & Surgical Hospitals, NEC · Fiscal year end 1231
Fundamental
51.0Momentum
87.5Acceleration
87.5Confidence
85.0Annual Revenue10
Quarterly Revenue40
Annual CFO18
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth6.5 / 25
Quality17.8 / 25
Capital Efficiency8.1 / 20
Balance Sheet6.1 / 15
Shareholder Economics10.0 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 0.6423 percentage points.
Operating leverageOperating margin improved by 7.4913 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Strong operating leverageOperating income is growing faster than revenue while operating margin expands.
Key Metrics
Revenue Growth TTM-4.14%OK
Revenue CAGR 3Y0.74%OK
Gross Margin85.25%OK
Operating Margin11.87%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC10.92%OK
Incremental Operating Margin 3Y1,684.21%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y2.73%OK
SBC / Revenue0.07%OK
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $12.49B | $10.62B | $1.49B | $543.00M | $208.00M | 85.07% | 11.92% | 1.67% | 15.23% | 135.01M |
| 2025 FY Dec 31, 2024 | $12.63B | $10.69B | $542.00M | $480.00M | $120.00M | 84.6% | 4.29% | 0.95% | 4.38% | 132.1M |
| 2025 FY Dec 31, 2023 | $12.49B | $10.50B | $957.00M | $210.00M | -$257.00M | 84.04% | 7.66% | -2.06% | 6.16% | 130.45M |
| 2024 FY Dec 31, 2022 | $12.21B | $10.24B | $821.00M | $300.00M | -$115.00M | 83.83% | 6.72% | -0.94% | 5.23% | 130.06M |
| 2023 FY Dec 31, 2021 | $12.37B | $10.33B | $1.40B | -$131.00M | -$600.00M | 83.49% | 11.34% | -4.85% | 10.78% | 130.6M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $12.01B | sum latest 4 fiscal quarters Revenue | OK | 0001193125-26-314196, 0001193125-25-250030 |
| Revenue Growth TTM | -4.14% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001193125-26-314196, 0001193125-25-250030 |
| Revenue CAGR 3Y | 0.74% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001193125-26-059509 |
| Revenue CAGR 5Y | 1.15% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001193125-26-059509 |
| Gross Profit CAGR 3Y | 1.24% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001193125-26-059509 |
| Operating Income Growth | 160.04% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0001193125-26-314196, 0001193125-25-250030 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 85.25% | Gross Profit / Revenue | OK | 0001193125-26-314196, 0001193125-25-250030 |
| Operating Margin | 11.87% | Operating Income / Revenue | OK | 0001193125-26-314196, 0001193125-25-250030 |
| ROIC | 10.92% | NOPAT / Average Invested Capital | OK | 0001193125-26-314196, 0001193125-25-250030 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001193125-26-314196 |
| Current Ratio | 1.53x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 0.02x | (Cash + Short-term Investments) / Total Debt | OK | 0001193125-26-314196 |
| SBC / Revenue | 0.07% | SBC / Revenue | OK | 0001193125-26-314196, 0001193125-25-250030 |